Cargando…

COVID-19 Vaccination Safety in Patients who have had SARS-CoV-2-induced Chilblains

Detalles Bibliográficos
Autores principales:	POIZEAU, Florence, TRIQUET, Louise, DUPUY, Alain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Publication of Acta Dermato-Venereologica 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631250/ https://www.ncbi.nlm.nih.gov/pubmed/35506360 http://dx.doi.org/10.2340/actadv.v102.888

Ejemplares similares

Long-term Outcome of Chilblains Associated with SARS-CoV-2
por: POIZEAU, Florence, et al.
Publicado: (2021)

Type I Interferon Signature in Chilblains Following SARS-CoV-2 mRNA Vaccine: A Case Report
por: SOUAID, Karim, et al.
Publicado: (2021)

Chilblains during lockdown are associated with household exposure to SARS-CoV-2: a multicentre case–control study
por: Poizeau, Florence, et al.
Publicado: (2022)

Chilblain-like Lesions after COVID-19 Vaccination: A Case Series
por: RUSSO, Roberto, et al.
Publicado: (2022)

SARS-CoV-2 variants in severely symptomatic and deceased persons who had been vaccinated against COVID-19 in São Paulo, Brazil
por: Campos, Karoline Rodrigues, et al.
Publicado: (2021)

Collodion in Chilblains
por: Evans, John
Publicado: (1851)

Pandemic chilblains: Are they SARS-CoV-2-related or not?
por: De Greef, Axel, et al.
Publicado: (2022)

Negative SARS-CoV-2 PCR in patients with chilblain-like lesions
por: Hubiche, Thomas, et al.
Publicado: (2021)

Aspects of maxillar osteomyelitis in patients who had COVID-19 in Uzbekistan
por: Boymuradov, Shukhrat A., et al.
Publicado: (2021)

Chilblain-like lesions coinciding with the SARS-CoV-2 pandemic
por: Starkey, Samantha Y., et al.
Publicado: (2022)

Le devenir à long terme des engelures induites par une exposition au SARS-CoV-2
por: Poizeau, Florence, et al.
Publicado: (2021)

Chilblain
Publicado: (1861)

Chilblains
Publicado: (1914)

Chilblains
Publicado: (1899)

Chilblains
Publicado: (1874)

Chilblains
Publicado: (1860)

SARS-CoV-2 und „Chilblains“: Dokumente einer leichten Infektion?
Publicado: (2021)

Lack of association between pandemic chilblains and SARS-CoV-2 infection
por: Gehlhausen, Jeff R., et al.
Publicado: (2022)

Risk factors associated with mortality among patients who had candidemia in a university hospital
por: Alves, Priscila Guerino Vilela, et al.
Publicado: (2020)

SARS-CoV-2 Vaccination and Chilblain-like Lesions: What Do We Know so Far?
por: Shaikh, Taha Gul, et al.
Publicado: (2022)

Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy
por: Bowes, Cynthia L., et al.
Publicado: (2022)

On the Treatment of Chilblains
Publicado: (1849)

Chilblain Lupus
por: Vinister, Ge vivin, et al.
Publicado: (2023)

Bioinformatics analysis reveals four major hexon variants of human adenovirus type-3 (HAdV-3) as the potential strains for development of vaccine and siRNA-based therapeutics against HAdV-3 respiratory infections
por: Panda, Somnath, et al.
Publicado: (2020)

SARS-CoV-2 infection in fully vaccinated healthcare workers
por: Hernández Porto, Miriam, et al.
Publicado: (2022)

COVID-19 vaccines and decreased transmission of SARS-CoV-2
por: Vitiello, A., et al.
Publicado: (2021)

Humoral and adaptive immune responses to the SARS-CoV-2 vaccine
por: Rizzo, Roberta, et al.
Publicado: (2022)

Immunologic skin signatures in SARS-CoV-2-negative patients with chilblain-like lesions
por: Vastarella, Maria, et al.
Publicado: (2021)

Safety of Pfizer-BioNTech vaccine in a cohort of healthcare providers: Differences between naïve and previously infected by SARS-CoV-2
por: Chong-Valbuena, Andrea, et al.
Publicado: (2022)

Safety of Percutaneous Endoscopic Gastrostomy Placement in Patients With SARS-CoV-2 Infection
por: Shah, Ayushi, et al.
Publicado: (2022)

Modeling strategies for the allocation of SARS-CoV-2 vaccines in the United States
por: Walker, Joseph, et al.
Publicado: (2022)

Exacerbation of Hailey-Hailey Disease Following SARS-CoV-2 Vaccination
por: ARMONI-WEISS, Gil, et al.
Publicado: (2021)

Vaccination against SARS-CoV-2 in a rural Ugandan population
por: Mugisha, Joseph, et al.
Publicado: (2023)

New insights in COVID-19–associated chilblains: A comparative study with chilblain lupus erythematosus
por: Battesti, Gilles, et al.
Publicado: (2020)

Ameliorated immunity elicited by intradermal inoculation in individuals vaccinated with inactivated SARS-CoV-2 vaccine
por: Fan, Shengtao, et al.
Publicado: (2021)

Vaccine breakthrough infections with SARS-CoV-2: Why older adults need booster vaccinations
por: Ventura, Maria I., et al.
Publicado: (2022)

Third of patients have gustatory dysfunction 9 months after SARS-CoV-2 infection: the ANOSVID study
por: Klopfenstein, Timothée, et al.
Publicado: (2022)

The Electric Bath for Chilblains
Publicado: (1899)

Chilblain Lupus Erythematosus
por: Shimamura, Yoshinosuke, et al.
Publicado: (2021)

Chilblains and Chapped Hands
Publicado: (1871)

Cannot write session to /tmp/vufind_sessions/sess_8vhac86q6te4kkb74h47f55bdc